Medical Countermeasures U.S. Commits $50 Million to Develop Countermeasures for Bundibugyo Ebola Strain Amid Growing DRC OutbreakGlobal Biodefense StaffJune 12, 2026
Medical Countermeasures CEPI Funds Three Bundibugyo Ebolavirus Vaccine Candidates, Including Oxford’s ChAdOx1-Based ApproachGlobal Biodefense StaffJune 1, 2026
Medical Countermeasures The Mpox Vaccine Works — But Its Immunity Fades Fast. A Third Dose May Help.Global Biodefense StaffMay 19, 2026
New Tuberculosis Drug Regimen Will Move to Landmark Phase 3 Trial Antimicrobial Resistance April 28, 2014 …
Rutgers Awarded $26M to Lead Development of New Antibiotics Antimicrobial Resistance April 28, 2014 …
Novel Agent for Tamiflu-Resistant pH1N1 Influenza Virus Discovered Medical Countermeasures April 24, 2014 …
